friends of mine and of a mate were, and are head of oncology at two major Sydney hospitals. Both were contacted by us about Imugenes prospects. Below is what each of them said:
Here’s some feedback from the head of oncology at (a major Sydney) Hospital…. results with CAR T cells are at least 5 - 10years off any outcomes. They are starting Phase1 trials … and need investors….. you would need to wait . The science is solid in lymphoma but they are more rare. Trials are starting in Solid tumours and the data there is still evolving
and the other:
The science certainly is valid.The clinical trial mooted with pembrolizumide woukd be appropriate.Encouraged by the FDA approval early.Probably all genuine.
friends of mine and of a mate were, and are head of oncology at...
-
- There are more pages in this discussion • 10,750 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
-0.003(4.84%) |
Mkt cap ! $433.6M | |||
| Open | High | Low | Value | Volume |
| 6.1¢ | 6.3¢ | 5.8¢ | $2.926M | 48.68M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 1489666 | 5.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.9¢ | 1250588 | 5 |
View Market Depth
| Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |